<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37937896</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>Changes in clinical, demographic, and outcome patterns of children hospitalized with non-SARS-CoV-2 viral low respiratory tract infections before and during the COVID pandemic in Rome, Italy.</ArticleTitle><Pagination><StartPage>362</StartPage><EndPage>370</EndPage><MedlinePgn>362-370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.26755</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We performed this study aiming to evaluate changes in epidemiology, clinical presentation and outcomes of children hospitalized for viral lower respiratory tract infections (LRTI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective study of children younger than 18 years of age hospitalized for LRTIs with a positive respiratory viral testing from 2018 to 2022. We compared need of pediatric intensive care unit (PICU), invasive ventilation, and other respiratory support, viral etiologies, clinical presentations, imaging, and laboratory results in the precovid (2018-2019) and covid (2020-2022) period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 523 were included in the analysis. In the pandemic period, the detection of influenza was 95% less likely to occur (odds ratio [OR]: 0.05; 95% confidence interval [95% CI]: 0.02-0.12; p &lt; .001), likewise the detection of adenovirus was 77% less likely to occur (OR: 0.23; 95% CI: 0.10-0.51; p &lt; .001). In the pandemic period, the number of codetections increased from 15.52% in 2018 to 57.25% in 2022, resulting in a significantly increasing trend (p &lt; .001). The odds of transfer to PICU was more than five times greater during the pandemic period (OR: 5.31; 95% CI: 1.78-15.86; p = .003).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found that the pattern of LRTI in children during COVID-19 pandemic significantly changed in terms of etiologies and increased severity.</AbstractText><CopyrightInformation>© 2023 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferro</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0401-9767</Identifier><AffiliationInfo><Affiliation>Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viozzi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0002-6999-0172</Identifier><AffiliationInfo><Affiliation>Medicine and Surgery, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bersani</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzareschi</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangelo</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Sanguinetti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie-Sezione di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiori</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>None</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012384" MajorTopicYN="N" Type="Geographic">Rome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adenovirus</Keyword><Keyword MajorTopicYN="N">coinfections</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">lower respiratory tract infections</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">viral infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37937896</ArticleId><ArticleId IdType="doi">10.1002/ppul.26755</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Bendavid E, Oh C, Bhattacharya J, Ioannidis JPA. Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19. Eur J Clin Invest. 2021;51(4):e13484. doi:10.1111/eci.13484</Citation></Reference><Reference><Citation>Lenglart L, Ouldali N, Honeyford K, et al. Respective roles of non-pharmaceutical interventions in bronchiolitis outbreaks: an interrupted time-series analysis based on a multinational surveillance system. Eur Respir J. 2023;61(2):2201172. doi:10.1183/13993003.01172-2022</Citation></Reference><Reference><Citation>Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect. 2021;83(3):281-293. doi:10.1016/j.jinf.2021.06.018</Citation></Reference><Reference><Citation>Bonacina F, Boëlle PY, Colizza V, Lopez O, Thomas M, Poletto C. Global patterns and drivers of influenza decline during the COVID-19 pandemic. Int J Infect Dis. 2023;128:132-139. doi:10.1016/j.ijid.2022.12.042</Citation></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1013.</Citation></Reference><Reference><Citation>Munro A, Buonsenso D, González-Dambrauskas S, et al. In-person schooling is essential even during periods of high transmission of COVID-19. BMJ Evid-Based Med. 2023;28(3):112277. doi:10.1136/bmjebm-2023-112277</Citation></Reference><Reference><Citation>Buonsenso D, Roland D, De Rose C, et al. Schools closures during the COVID-19 pandemic: a catastrophic global situation. Pediatr Infect Dis J. 2021;40(4):e146-e150. doi:10.1097/INF.0000000000003052</Citation></Reference><Reference><Citation>Amar S, Avni YS, O'Rourke N, Michael T. Prevalence of common infectious diseases after COVID-19 vaccination and easing of pandemic restrictions in Israel. JAMA Network Open. 2022;5(2):e2146175. doi:10.1001/jamanetworkopen.2021.46175</Citation></Reference><Reference><Citation>Camporesi A, Morello R, Ferro V, et al. Epidemiology, microbiology and severity of bronchiolitis in the first Post-Lockdown cold season in three different geographical areas in Italy: A prospective, observational study. Children. 2022;9(4):491. doi:10.3390/children9040491</Citation></Reference><Reference><Citation>Gupta NA, Romero R. Post hoc, ergo propter hoc? evaluating a potential increase in childhood severe hepatitis in a post-COVID world. J Pediatric Infect Dis Soc. 2022;11(8):354-356. doi:10.1093/jpids/piac054</Citation></Reference><Reference><Citation>McNeil JC, Flores AR, Kaplan SL, Hulten KG. The indirect impact of the SARS-CoV-2 pandemic on invasive group a streptococcus, Streptococcus pneumoniae and Staphylococcus Aureus infections in Houston Area Children. Pediatr Infect Dis J. 2021;40(8):e313-e316. doi:10.1097/INF.0000000000003195</Citation></Reference><Reference><Citation>Cohen R, Ashman M, Taha MK, et al. Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51(5):418-423. doi:10.1016/j.idnow.2021.05.004</Citation></Reference><Reference><Citation>Milani GP, Buonsenso D, Marchisio P, et al. Gastroenteritis is less severe but is more often associated with systemic inflammation in SARS-CoV-2-positive than in SARS-CoV-2-negative children. Pediatr Infect Dis J. 2023;42(9):e320. doi:10.1097/INF.0000000000004001</Citation></Reference><Reference><Citation>Lade H, Kim JM, Chung Y, Han M, Mo EK, Kim JS. Comparative evaluation of allplex respiratory panels 1, 2, 3, and BioFire FilmArray respiratory panel for the detection of respiratory infections. Diagnostics. 2021;12(1):9. doi:10.3390/diagnostics12010009</Citation></Reference><Reference><Citation>Parčina M, Schneider UV, Visseaux B, Jozić R, Hannet I, Lisby JG. Multicenter evaluation of the QIAstat respiratory panel-a new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections. PLoS One. 2020;15(3):e0230183. doi:10.1371/journal.pone.0230183</Citation></Reference><Reference><Citation>Jarrett J, Uhteg K, Forman MS, et al. Clinical performance of the GenMark Dx eplex respiratory pathogen panels for upper and lower respiratory tract infections. J Clin Virol. 2021;135:104737. doi:10.1016/j.jcv.2021.104737</Citation></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2022;21:195-210. doi:10.1038/s41579-022-00807-9</Citation></Reference><Reference><Citation>Di Mattia G, Nenna R, Mancino E, et al. During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. 2021;56(10):3106-3109. doi:10.1002/ppul.25582</Citation></Reference><Reference><Citation>Buonsenso D, Valentini P, Moscato U, Ricciardi W, Roland D. A pediatric strategy for the next phase of the SARS-CoV-2 pandemic. Front Pediatr. 2020;8:582798. doi:10.3389/fped.2020.582798</Citation></Reference><Reference><Citation>Nygaard U, Hartling UB, Nielsen J, et al. Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort study. Lancet Child Adolesc Health. 2023;7(3):171-179. doi:10.1016/S2352-4642(22)00371-6</Citation></Reference><Reference><Citation>Kollmann TR, Crabtree J, Rein-Weston A, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol. 2009;183(11):7150-7160. doi:10.4049/jimmunol.0901481</Citation></Reference><Reference><Citation>Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821):20143085. doi:10.1098/rspb.2014.3085</Citation></Reference><Reference><Citation>Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98(5):708-715. doi:10.1016/S0022-3476(81)80829-3</Citation></Reference><Reference><Citation>Stensballe LG, Ravn H, Kristensen K, et al. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol. 2009;123(2):398-403. doi:10.1016/j.jaci.2008.10.043</Citation></Reference><Reference><Citation>Rodriguez-Fernandez R, Mejias A, Ramilo O. Monoclonal antibodies for prevention of respiratory syncytial virus infection. Pediatr Infect Dis J. 2021;40(5S):S35-S39. doi:10.1097/INF.0000000000003121</Citation></Reference><Reference><Citation>Esposito S, Abu Raya B, Baraldi E, et al. RSV prevention in all infants: which is the most preferable strategy. Front Immunol. 2022;13:880368. doi:10.3389/fimmu.2022.880368</Citation></Reference><Reference><Citation>Binns E, Koenraads M, Hristeva L, et al. Influenza and respiratory syncytial virus during the COVID-19 pandemic: time for a new paradigm? Pediatr Pulmonol. 2022;57(1):38-42. doi:10.1002/ppul.25719</Citation></Reference><Reference><Citation>Buonsenso D, Valentini P, De Rose C, et al. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J Clin Med. 2022;11(15):4363. doi:10.3390/jcm11154363</Citation></Reference><Reference><Citation>Hatter L, Eathorne A, Hills T, Bruce P, Beasley R. Respiratory syncytial virus: paying the immunity debt with interest. Lancet Child Adolesc Health. 2021;5(12):e44-e45. doi:10.1016/S2352-4642(21)00333-3</Citation></Reference><Reference><Citation>Wang C, Zhou X, Wang M, Chen X. The impact of SARS-CoV-2 on the human immune system and microbiome. Infect Microbes Dis. 2021;3(1):14-21. doi:10.1097/IM9.0000000000000045</Citation></Reference><Reference><Citation>Sutradhar J, Sarkar BR. The effect on the immune system in the human body due to COVID-19: an insight on traditional to modern approach as a preventive measure. J Pharmacopunct. 2021;24(4):165-172. doi:10.3831/KPI.2021.24.4.165</Citation></Reference><Reference><Citation>Di Sante G, Buonsenso D, De Rose C, et al. Immunopathology of SARS-CoV-2 infection: a focus on T regulatory and B cell responses in children compared with adults. Children. 2022;9(5):681. doi:10.3390/children9050681</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>